Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Intas Pharmaceuticals Announces Acquisition of Hospital Business in Spain and Portugal From Combino Pharm, a Company Based Out of Spain


News provided by

Intas Pharmaceuticals Limited

18 Mar, 2015, 17:17 IST

Share this article

Share toX

Share this article

Share toX

AHMEDABAD, India, March 18, 2015 /PRNewswire/ --

Intas Pharmaceuticals Limited, one of India's fastest growing pharmaceutical companies, today announced that it has acquired hospital business in Spain and Portugal from Combino Pharm, a company based out of Spain through its subsidiary Accord Healthcare based out of UK and Spain.

Mr. Binish Chudgar, Vice Chairman and Managing Director of Intas, said, "By means of this acquisition, Accord obtains certain rights over Combino's Hospital portfolio in a number of European and non-European countries. The acquisition offers lot of synergies to Accord's already existing sizeable business in Spain and further strengthens and expand its operations in Spain and Portugal with a broader and more robust portfolio of products. Through this acquisition, combined business of both the entities would become the 2nd largest hospital generic player in Spain."

About Intas 

Intas is a leading, vertically integrated global pharmaceutical company from India, having end-to-end capabilities of formulation development, manufacturing and marketing along with backward integration of APIs. Intas' success and incessant growth focus lies in its clinical execution of successful and strategic moves made in the areas of manufacturing, R & D, biotechnology and global operations over the past three decades. Intas has been growing at 27% CAGR over the last 5 years with an even stronger profit growth. Ranked 12th in the domestic market (As per IMS India December, 2014 MAT figures ), the company is one of the top 5 corporates in the Indian Chronic Therapy category. Intas is also present in more than 70 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central & Latin America, Africa, Australia, New Zealand, Asia-Pacific as well as CIS and MENA countries. Today about 55% of the total sales comes from global operations. For more information on Intas, please visit  www.intaspharma.com.

Media Contact

Gaurang Darji
[email protected]
+91-9925038960
Sr. General Manager - Corporate Affairs
One Advertising & Communication Services Ltd.

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.